GR3021705T3 - Purified ciliary neurotrophic factor - Google Patents

Purified ciliary neurotrophic factor

Info

Publication number
GR3021705T3
GR3021705T3 GR960403098T GR960403098T GR3021705T3 GR 3021705 T3 GR3021705 T3 GR 3021705T3 GR 960403098 T GR960403098 T GR 960403098T GR 960403098 T GR960403098 T GR 960403098T GR 3021705 T3 GR3021705 T3 GR 3021705T3
Authority
GR
Greece
Prior art keywords
neurotrophic factor
ciliary neurotrophic
purified
purified ciliary
factor
Prior art date
Application number
GR960403098T
Other languages
English (en)
Inventor
Franklin D Collins
Leu-Fen Lin
Drzislav Mismer
Christine Ko
Original Assignee
Amgen Boulder Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/293,851 external-priority patent/US5011914A/en
Priority claimed from US07/404,533 external-priority patent/US4997929A/en
Application filed by Amgen Boulder Inc filed Critical Amgen Boulder Inc
Publication of GR3021705T3 publication Critical patent/GR3021705T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
GR960403098T 1989-01-05 1996-11-20 Purified ciliary neurotrophic factor GR3021705T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/293,851 US5011914A (en) 1989-01-05 1989-01-05 Purified ciliary neurotrophic factor
US07/404,533 US4997929A (en) 1989-01-05 1989-09-08 Purified ciliary neurotrophic factor
US07/458,564 US5141856A (en) 1989-01-05 1989-12-28 Expression of purified ciliary neurotrophic factor

Publications (1)

Publication Number Publication Date
GR3021705T3 true GR3021705T3 (en) 1997-02-28

Family

ID=27404236

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960403098T GR3021705T3 (en) 1989-01-05 1996-11-20 Purified ciliary neurotrophic factor

Country Status (21)

Country Link
US (2) US5141856A (el)
EP (1) EP0385060B1 (el)
JP (2) JPH0768270B2 (el)
KR (1) KR930012105B1 (el)
AU (1) AU7032496A (el)
BR (1) BR9006996A (el)
CH (1) CH681426A5 (el)
DD (1) DD299318A5 (el)
DE (1) DE4090006C2 (el)
DK (1) DK131391A (el)
ES (1) ES2091768T3 (el)
FI (1) FI104375B (el)
GB (1) GB2246132B (el)
GR (1) GR3021705T3 (el)
HU (2) HUT58792A (el)
IE (1) IE81151B1 (el)
IL (1) IL92958A (el)
NL (1) NL9020024A (el)
NZ (1) NZ231985A (el)
SE (1) SE513358C2 (el)
WO (1) WO1990007341A1 (el)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714585A (en) * 1987-10-26 1998-02-03 Sterling Winthrop, Inc. Antibodies that are immunoreactive with interleukin-7
US5328988A (en) * 1987-10-26 1994-07-12 Immunex Corporation Interleukin-7
US5141856A (en) * 1989-01-05 1992-08-25 Synergen, Inc. Expression of purified ciliary neurotrophic factor
IE903130A1 (en) * 1989-09-15 1991-03-27 Regeneron Pharma Ciliary neurotrophic factor
IL97557A0 (en) * 1990-03-14 1992-06-21 Fidia Spa Process for the isolation and expression of the human ciliary neuronotrophic factor by recombinant dna technology
US6511823B1 (en) * 1990-08-20 2003-01-28 American Cyanamid Corporation Heparin binding neurotrophic factor gene sequence
IT1247150B (it) * 1991-01-21 1994-12-12 Fidia Spa Processo per la sintesi e la purificazione del fattore neuronotroficociliare umano (cntf) da escherichia coli.
US5593857A (en) * 1991-08-23 1997-01-14 Scios Inc. Production of homogeneous truncated CNTF
CA2123234A1 (en) * 1991-11-11 1993-05-27 Lanfranco Callegaro Synthesis and purification of truncated and mutein forms of human ciliary neuronotrophic factor
US5360740A (en) * 1992-07-02 1994-11-01 Regeneron Pharmaceuticals, Inc. Assay system for degenerative muscle disease
ZA94608B (en) * 1993-01-29 1994-09-15 Regeneron Pharma Use of ciliary neurotrophic factor in a method of treating a neurological disorder
TW248552B (el) * 1993-06-01 1995-06-01 Onoda Yakuhin Kogyo Kk
WO1995022560A1 (en) * 1994-02-22 1995-08-24 The Syntex-Synergen Neuroscience Joint Venture Pharmaceutical formulations of cntf
US5534615A (en) * 1994-04-25 1996-07-09 Genentech, Inc. Cardiac hypertrophy factor and uses therefor
EP0755446B1 (en) * 1994-04-25 2006-09-13 Genentech, Inc. Cardiotrophin and uses therefor
US7258983B2 (en) * 1994-04-25 2007-08-21 Genentech, Inc. Cardiotrophin-1 compositions and methods for the treatment of tumor
US6472585B1 (en) 1994-04-25 2002-10-29 Genentech, Inc. Cardiotrophin-1 defective mouse
US5739307A (en) * 1995-08-28 1998-04-14 Washington University Polynucleotide encoding neurturin neurotrophic factor
US6743628B1 (en) 1995-08-28 2004-06-01 Washington University Method of cell culture using neurturin
US7015316B1 (en) 1996-03-14 2006-03-21 Washington University Polynucleotides encoding human persephin and related growth factors
EP0886651B1 (en) 1996-03-14 2005-01-26 Washington University Persephin and related growth factors
US6222022B1 (en) 1996-03-14 2001-04-24 Washington University Persephin and related growth factors
US6299895B1 (en) 1997-03-24 2001-10-09 Neurotech S.A. Device and method for treating ophthalmic diseases
IT1288388B1 (it) * 1996-11-19 1998-09-22 Angeletti P Ist Richerche Bio Uso di sostanze che attivano il recettore del cntf ( fattore neurotrofico ciliare) per la preparazione di farmaci per la terapia
US6042579A (en) * 1997-04-30 2000-03-28 Medtronic, Inc. Techniques for treating neurodegenerative disorders by infusion of nerve growth factors into the brain
US6689573B1 (en) * 1999-05-24 2004-02-10 New England Biolabs, Inc. Method for screening restriction endonucleases
WO2001078789A2 (en) 2000-04-14 2001-10-25 The Uab Research Foundation Poliovirus replicons encoding therapeutic agents and uses thereof
US20050064555A1 (en) * 2003-07-09 2005-03-24 Xencor, Inc. Ciliary neurotrophic factor variants
US20100143500A1 (en) * 2006-10-31 2010-06-10 The Ohio State University Research Foundation Methods and Compositions for Inhibiting GSK-3 In Glial Cell Related Disorders
EP2646007B1 (en) 2010-12-02 2016-12-21 Neurotech USA, Inc. Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereof
AU2016267579B2 (en) 2015-05-27 2024-02-01 Neurotech Usa, Inc. Use of encapsulated cell therapy for treatment of ophthalmic disorders

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US293851A (en) * 1884-02-19 de castro
US429517A (en) * 1890-06-03 Packing-box
US408172A (en) * 1889-07-30 Steam-boiler house
US458564A (en) * 1891-09-01 Ring-gage
US570651A (en) * 1896-11-03 Motor-driven fan
US404533A (en) * 1889-06-04 Signments
US4399216A (en) * 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4923696A (en) * 1987-05-04 1990-05-08 Baylor College Of Medicine Method to prepare a neurotrophic composition
US5028622A (en) * 1988-05-06 1991-07-02 Ajinomoto Company, Inc. Administration of amino acids as treatment for neurodegenerative disorders
US5141856A (en) * 1989-01-05 1992-08-25 Synergen, Inc. Expression of purified ciliary neurotrophic factor
US4997929A (en) * 1989-01-05 1991-03-05 Synergen, Inc. Purified ciliary neurotrophic factor
US5011914A (en) * 1989-01-05 1991-04-30 Collins Franklin D Purified ciliary neurotrophic factor
WO1990010647A1 (en) * 1989-03-15 1990-09-20 The Regents Of The University Of California Purified ciliary neurotrophic factor
FI912358A0 (fi) * 1989-09-15 1991-05-15 Max Planck Gesellschaft Neurotrofisk faktor av ciliar ganglion.
IE903130A1 (en) * 1989-09-15 1991-03-27 Regeneron Pharma Ciliary neurotrophic factor
US5349056A (en) * 1992-10-09 1994-09-20 Regeneron Pharmaceuticals Modified ciliary neurotrophic factors

Also Published As

Publication number Publication date
AU4838190A (en) 1990-08-01
GB2246132B (en) 1993-09-15
NL9020024A (nl) 1991-10-01
EP0385060A2 (en) 1990-09-05
HUT58792A (en) 1992-03-30
AU7032496A (en) 1997-01-16
GB2246132A8 (en) 2001-05-22
KR910700068A (ko) 1991-03-13
HU211933A9 (en) 1996-01-29
US5780600A (en) 1998-07-14
SE513358C2 (sv) 2000-08-28
DD299318A5 (de) 1992-04-09
GB9113704D0 (en) 1991-08-21
GB2246132A (en) 1992-01-22
JPH0768270B2 (ja) 1995-07-26
BR9006996A (pt) 1991-11-12
IL92958A (en) 1997-09-30
US5141856A (en) 1992-08-25
IE81151B1 (en) 2000-05-03
DK131391D0 (da) 1991-07-05
ES2091768T3 (es) 1996-11-16
EP0385060A3 (en) 1991-04-03
DE4090006C2 (de) 1996-09-19
IL92958A0 (en) 1990-09-17
IE900020L (en) 1990-07-05
SE9102079L (sv) 1991-07-03
DK131391A (da) 1991-09-05
WO1990007341A1 (en) 1990-07-12
FI913251A0 (fi) 1991-07-04
CH681426A5 (el) 1993-03-31
EP0385060B1 (en) 1996-08-28
FI104375B (fi) 2000-01-14
KR930012105B1 (ko) 1993-12-24
AU642858B2 (en) 1993-11-04
JPH04502916A (ja) 1992-05-28
JPH1129598A (ja) 1999-02-02
NZ231985A (en) 1992-12-23
SE9102079D0 (sv) 1991-07-03

Similar Documents

Publication Publication Date Title
GB2246132A (en) Purified ciliary neurotrophic factor
ZA9081B (en) Purified ciliary neurotrophic factor
LTIP1546A (en) Cerebral neurothropic factor
AU108998S (en) Lamp
GB2228528B (en) Stay
EP0423928A3 (en) Multi-ferrule structure
IL94829A0 (en) Indenoindoles i
GB9027564D0 (en) Microlaminated structure
IL95678A0 (en) Novel alkanophenones
GB2239467B (en) Support structure
GB2227788B (en) Stay
ZA907303B (en) Ciliary neurotrophic factor
GB8903631D0 (en) Can ends
HUT60012A (en) Height-limiting structure
IL83686A0 (en) Neurotrophic factor
IL95679A0 (en) Novel alkanophenones
NO964837D0 (no) Renset ciliær neurotrofisk faktor
HUT56427A (en) Door-case structure
HUT60011A (en) Height-limiting structure
GB8927241D0 (en) Kerbing structure
CA63830S (en) Support
IE894206L (en) Novel immunoglobulins
CS456188A2 (en) Profile inductor
AU111962S (en) Profile
GB8924818D0 (en) Support structure